Αρχειοθήκη ιστολογίου

Δευτέρα 4 Φεβρουαρίου 2019

Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement

Allergic rhinitis (AR) affects 23–30% of the European population with equal prevalence reported in Belgium. Despite guidelines on the correct use of effective treatment, up to 40% of AR patients remain uncontr...

http://bit.ly/2Sur9hO

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου